Evidence map›Paper›PMID 28018340›Full record

ArticleFrontiers in immunology2016

Analysis of the Interaction between Globular Head Modules of Human C1q and Its Candidate Receptor gC1qR.

Lina Pednekar, Ansar A Pathan, Basudev Paudyal, Anthony G Tsolaki, Anuvinder Kaur, Suhair M Abozaid, Lubna Kouser, Haseeb A Khan, Ellinor I Peerschke, Mohamed H Shamji and 3 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
0.8field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 21 citations in OpenAlex.

  1. The Complement System.Advances in experimental medicine and biology · 2025
    Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Frontiers in immunology · 2020
    Article
  9. Review
  10. Phylogenetically Defined Isoforms ofInternational journal of molecular sciences · 2019
    Article
  11. Article
  12. Review
  13. Complement Protein C1q Interacts with DC-SIGNFrontiers in immunology · 2016
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 3 countries.

Lina PednekarBiosciences, College of Health and Life Sciences, Brunel University London , London , UK.
Ansar A PathanBiosciences, College of Health and Life Sciences, Brunel University London , London , UK.
Basudev PaudyalBiosciences, College of Health and Life Sciences, Brunel University London , London , UK.
Anthony G TsolakiBiosciences, College of Health and Life Sciences, Brunel University London , London , UK.
Anuvinder KaurBiosciences, College of Health and Life Sciences, Brunel University London , London , UK.
Suhair M AbozaidBiosciences, College of Health and Life Sciences, Brunel University London , London , UK.
Lubna KouserBiosciences, College of Health and Life Sciences, Brunel University London , London , UK.
Haseeb A KhanDepartment of Biochemistry, College of Science, King Saud University , Riyadh , Saudi Arabia.
Ellinor I PeerschkeDepartment of Laboratory Medicine, Memorial Sloan-Kettering, Cancer Center , New York, NY , USA.
Mohamed H ShamjiAllergy and Clinical Immunology, National Heart and Lung Institute, Imperial College London , London , UK.
Gudrun StenbeckBiosciences, College of Health and Life Sciences, Brunel University London , London , UK.
Berhane GhebrehiwetDepartment of Medicine, State University of New York , Stony Brook, NY , USA.
Uday KishoreBiosciences, College of Health and Life Sciences, Brunel University London , London , UK.
Brunel University of London · GBImperial College London · GBKing Saud University · SAMemorial Sloan Kettering Cancer Center · USState University of New York · US

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4M
NCI NIH HHS P30 CA008748
6 · The paper itself

Abstract

The heterotrimeric globular head (gC1q) domain of human C1q is made up of the C-terminal ends of the three individual chains, ghA, ghB, and ghC. A candidate receptor for the gC1q domain is a multi-functional pattern recognition protein, gC1qR. Since understanding of gC1qR and gC1q interaction could provide an insight into the pleiotropic functions of gC1qR, this study was undertaken to identify the gC1qR-binding site on the gC1q domain, using the recombinant ghA, ghB, and ghC modules and their substitution mutants. Our results show that ghA, ghB, and ghC modules can interact with gC1qR independently, thus reinforcing the notion of modularity within the gC1q domain of human C1q. Mutational analysis revealed that while Arg162 in the ghA module is central to interaction between gC1qR and C1q, a single amino acid substitution (arginine to glutamate) in residue 114 of the ghB module resulted in enhanced binding. Expression of gC1qR and C1q in adherent monocytes with or without pro-inflammatory stimuli was also analyzed by qPCR; it showed an autocrine/paracrine basis of C1q and gC1qR interaction. Microscopic studies revealed that C1q and gC1qR are colocalized on PBMCs. Cell proliferation assays indicated that ghA, ghB, and ghC modules were able to attenuate phytohemagglutinin-stimulated proliferation of PBMCs. Addition of gC1qR had an additive effect on the anti-proliferative effect of globular head modules. In summary, our results identify residues involved in C1q-gC1qR interaction and explain, to a certain level, their involvement on the immune cell surface, which is relevant for C1q-induced functions including inflammation, infection, and immunity.

Indexed as

C1qcell proliferationgC1qRglobular headprotein–protein interaction

Identifiers

PMID28018340
PMCPMC5153404
OpenAlexW2567257409

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.